InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to ...

The firm is scheduled to report its financial performance for Q4 and fiscal 2025 ahead of the market open on Tuesday, Feb. 10 ...

InMode (NASDAQ: INMD) is a medical device company that provides its consumers with a wide range of treatments to help with contouring skin, treating acne, removing hair, and other aesthetic issues.

Investing in stocks inevitably means buying into some companies that perform poorly. Long term InMode Ltd. (NASDAQ:INMD) shareholders know that all too well, since the share price is down considerably ...

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable ...

InMode is a small-cap medical device company that invented a new way to do plastic surgery in a non-invasive way, via radio waves. The company is dominating its niche market, and the stock is up ...

Inmode ((INMD)) has held its Q3 earnings call. Read on for the main highlights of the call. InMode’s recent earnings call revealed a mixed sentiment, with positive developments in international ...

InMode, known for radiofrequency microneedling technology in cosmetic applications, faces a blend of market opportunities and financial challenges. INMD's innovative products like Morpheus8 and Evolve ...